Kyverna Therapeutics (KYTX) stock gets a Strong Buy on miv-cel’s clinical wins and 2026 BLA timing. Read the full analysis ...
Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff ...
Wiss points to the problem of limited literacy in healthcare systems, as well as the criminal justice system. The US ...
The drug, reproxalap, led to reductions in symptoms of dry eye, but regulators have repeatedly refused to approve it for this ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, randomized controlled trial highlighting the clinical superiorit ...
Alkermes plc today announced plans to present new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the American Academy of Neurology (AAN) 2026 ...
Pediatric researchers at Oregon Health & Science University have found that applying a plain emollient – including petroleum ...
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
Jallah, T.T. (2026) Beyond Financial Access: The Association between Financial Inclusion and Women’s Economic Empowerment in Montserrado County, Liberia. Open Access Library Journal, 13, 1-24. doi: 10 ...
Supplements like vitamin C, collagen, probiotics, and vitamin A can help improve your overall skin appearance and reduce ...
Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of high-risk infections and pre-cancerous lesions caused by human papillomavirus (HPV) in women ...